These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 16158922

  • 1. Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculature.
    Shnyder SD, Hasan J, Cooper PA, Pilarinou E, Jubb E, Jayson GC, Bibby MC.
    Anticancer Res; 2005; 25(3B):1889-94. PubMed ID: 16158922
    [Abstract] [Full Text] [Related]

  • 2. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N, Khramtsov A, Ahmed S, Nallasura V, Hetzel JT, Jagadeeswaran R, Karczmar G, Salgia R.
    Cancer Res; 2007 Apr 15; 67(8):3529-34. PubMed ID: 17440059
    [Abstract] [Full Text] [Related]

  • 3. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R.
    Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869
    [Abstract] [Full Text] [Related]

  • 4. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK, Ha JM, O E, Lee BH, Lee SK, Shim BS, Hong YK, Joe YA.
    Cancer Res; 2007 May 15; 67(10):4851-9. PubMed ID: 17510415
    [Abstract] [Full Text] [Related]

  • 5. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
    Hsu SC, Ou CC, Chuang TC, Li JW, Lee YJ, Wang V, Liu JY, Chen CS, Lin SC, Kao MC.
    Cancer Lett; 2009 Aug 18; 281(1):108-16. PubMed ID: 19332363
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effects of synthetic VEGF-receptor binding antagonist, VGA1155.
    Ueda Y, Yamagishi T, Samata K, Hirayama N, Aozuka Y, Tanaka M, Nakaike S, Saiki I.
    Anticancer Res; 2005 Aug 18; 25(6B):3973-7. PubMed ID: 16309186
    [Abstract] [Full Text] [Related]

  • 7. The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer.
    Fu J, Ding Y, Huang D, Li H, Chen X.
    Cancer Lett; 2007 Apr 08; 248(1):153-63. PubMed ID: 17027148
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
    Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ.
    Oncol Rep; 2008 Sep 08; 20(3):581-7. PubMed ID: 18695909
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
    Landen CN, Lu C, Han LY, Coffman KT, Bruckheimer E, Halder J, Mangala LS, Merritt WM, Lin YG, Gao C, Schmandt R, Kamat AA, Li Y, Thaker P, Gershenson DM, Parikh NU, Gallick GE, Kinch MS, Sood AK.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1558-70. PubMed ID: 17077358
    [Abstract] [Full Text] [Related]

  • 11. [Angiogenesis and lung cancer].
    Pérol M, Arpin D.
    Bull Cancer; 2007 Jul 01; 94 Spec No():S220-31. PubMed ID: 17846008
    [Abstract] [Full Text] [Related]

  • 12. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 13. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 14. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM, Lingwood CA.
    Angiogenesis; 2003 Nov 17; 6(2):129-41. PubMed ID: 14739619
    [Abstract] [Full Text] [Related]

  • 15. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The actual place of anti-angiogenesis in non-small cell lung cancer].
    Mennecier B.
    Rev Mal Respir; 2007 Oct 01; 24(8 Pt 2):6S198-205. PubMed ID: 18235414
    [Abstract] [Full Text] [Related]

  • 18. The hollow fibre model--facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare.
    Suggitt M, Cooper PA, Shnyder SD, Bibby MC.
    Int J Oncol; 2006 Dec 01; 29(6):1493-9. PubMed ID: 17088988
    [Abstract] [Full Text] [Related]

  • 19. The hollow fibre model in cancer drug screening: the NCI experience.
    Decker S, Hollingshead M, Bonomi CA, Carter JP, Sausville EA.
    Eur J Cancer; 2004 Apr 01; 40(6):821-6. PubMed ID: 15120037
    [Abstract] [Full Text] [Related]

  • 20. [Angiogenesis and neoangiogenesis--the role in lung cancer and other tumors].
    Swidzińska E, Naumnik W, Chyczewska E.
    Pneumonol Alergol Pol; 2006 Apr 01; 74(4):414-20. PubMed ID: 17427152
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.